DexCom (NASDAQ:DXCM) has received a short term rating of hold from experts at Zacks with a rank of 3. The stock has been rated an average of 1.68 by 14 Brokerage Firm. 9 Wall Street Firms have rated the stock as a strong buys. 2 stock experts have also suggested a buy rating. 2 Brokerage Firms have advised hold. 1 Analysts have rated it as strong sell.
Other Equity analysts have also commented on the company shares. BTIG Research initiates coverage on DexCom (NASDAQ:DXCM). The shares have now been rated Buy by the stock experts at the ratings house. BTIG Research announces the current price target of $80 per share on DexCom . The rating by the firm was issued on April 14, 2016.
DexCom (NASDAQ:DXCM): 13 analysts have set the short term price target of DexCom (NASDAQ:DXCM) at $87.6. The standard deviation of short term price target has been estimated at $13.21, implying that the actual price may fluctuate by this value. The higher and the lower price estimates are $ 112 and $57 respectively.
DexCom (NASDAQ:DXCM) rose 0.35% or 0.27 points on Tuesday and made its way into the gainers of the day. After trading began at $77.74 the stock was seen hitting $77.74 as a peak level and $75.55 as the lowest level. The stock ended up at $77.51. The daily volume was measured at 1,152,381 shares. The 52-week high of the share price is $103.29 and the 52-week low is $47.92. The company has a market cap of $6,467 million.
Shares of DexCom, Inc. rose by 5.6% in the last five trading days and 21.45% for the last 4 weeks. DexCom, Inc. is up 23.64% in the last 3-month period. Year-to-Date the stock performance stands at -5.36%.
Dexcom, Inc. (Dexcom) is a medical device company. The Company is focused on the design, development and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers for the treatment of people with and without diabetes. Its products consist of DexCom G4, DexCom G4 PLATINUM and DexCom Share System. The DexCom G4 PLATINUM with Share uses a wireless connection between a patients receiver and an application on the patients iPhone to transmit glucose information to applications on the mobile devices of up to five designated recipients or followers, who can remotely monitor a patients glucose information and receive alert notifications anywhere they have an Internet connection. SweetSpots data transfer service is a Medical Device Data System (MDDS) and allows researchers to control the transfer of data from certain diabetes devices to research tools and databases according to their own research workflows.